AFFF cancer lawsuit

Firefighters Are At Risk Of Developing Prostate Cancer From Using Firefighting Foam

Military and other firefighters now have answers to their questions about what may have caused their prostate cancer

Thursday, July 20, 2023 - US Marines are filing AFFF cancer lawsuits against 3M, DuPont, and other firefighting foal manufacturers that allege working with AFFF regularly for many years with the toxic fire suppressant caused them to develop kidney, testicular, and in at least one specific instance, prostate cancer. According to AboutLawsuits.com, US Marine Bruce Allen has filed an AFFF prostate cancer lawsuit against the above manufacturers of AFFF seeking monetary compensation for lost wages, medical expenses, and pain and suffering. Thousands of AFFF cancer lawsuits are expected in the months to come as more and more firefighters with cancer learn that using the deadly foam is their disease's probable cause. Firefighters may be exposed to Aqueous Film-Forming Foam (AFFF) while tackling fires involving flammable liquids. AFFF contains perfluoroalkyl and poly-fluoroalkyl substances (PFAS) that suppress fires effectively. Exposure can occur through inhalation of airborne particles, skin contact with the foam, or ingestion during firefighting operations. PFAS compounds have been associated with health concerns, so proper protective gear, like respirators and gloves, is essential. Firefighters should follow decontamination procedures to minimize exposure risks after handling AFFF-contaminated areas. Training on handling hazardous materials and awareness of AF's potential risks is vital for their safety. Periodic health screenings are advisable to monitor any adverse effects. Several companies AF firefighting foam manufacturers are accused of failing to warn the military and other firefighters of the dangers of using toxic AFFF.

AFFF is made from PFAS forever chemicals with molecular bonds so strong that they can instantly extinguish petroleum and jet fuel fires. Unfortunately, those same characteristics also lend the name "forever" to the chemical. Forever chemicals never break down into organic compounds and bio-accumulate in everything they come into contact with, including rainwater. Ingesting the compound may lead to several types of terminal cancer. Firefighting foam, especially Aqueous Film-Forming Foam (AFFF), has been linked to potential cancer risks due to its content of perfluoroalkyl and poly-fluoroalkyl substances (PFAS). These chemicals can leach into the environment and accumulate in the human body, posing health concerns. According to a scientific study published in the Environmental Science & Technology Letters, researchers stated, "PFAS exposure has been associated with increased cancer risk." Firefighters handling AFFF during firefighting operations are at risk of exposure through inhalation, skin contact, and ingestion, making it crucial to adhere to safety protocols and implement preventive measures to safeguard their health. Prostate cancer's early warning signs are subtle but crucial to detect. Patients may experience urinary changes, such as increased frequency, difficulty starting or stopping urine flow, or weak urine stream. Persistent pain or discomfort in the pelvic region, back, or hips might occur. Additionally, blood in urine or semen, as well as erectile dysfunction, could occur. These signs are often associated with other non-cancerous conditions, underscoring the importance of consulting a healthcare professional for proper evaluation. Regular screenings and early detection can significantly improve outcomes. Remember, don't delay seeking medical advice if any of these symptoms arise; it could be lifesaving.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.